San Francisco-based AI lab Radical Numerics announced the development this week, describing it as the first administration of a cocktail containing AI-designed bacteriophages to a human under a compassionate-use pathway.
The treatment relied on Omnii-1, a newly unveiled AI model created by the company specifically to generate viable bacteriophages—viruses that infect and kill bacteria. While phage therapy itself is not new, the use of AI to design the viruses marks a sharp acceleration of efforts to combat rising antimicrobial resistance....<<<Read More>>>...
